PCSK9 inhibitors may be appropriate for use in patients with ACS
Because PCSK9 is elevated after ACS PCSK9 inhibitors could benefit patients with ACS according to a review published in the Annals of Internal Medicine.The PCSK9 inhibitors alirocumab Praluent...
View ArticleSkipping meds greatly ups heart patients' risk of stroke study
HealthDayPeople at risk for heart disease are much more likely to die from a stroke if they don't take cholesterollowering statin drugs and blood pressure medications as prescribed a new study reports.
View Article7 Vitamins & Supplements Primary Care Doctors Recommend
And No They Dont Come in a Single Pill When it comes to vitamins and supplements what are the best ones to consider Can you take too much and what happens if you do Should your doctor know your vitamin...
View ArticleMerck to Present New Findings from Chronic Hepatitis C Clinical Development...
Presentations Include Results from Phase 3 Study Evaluating ZEPATIER elbasvir and grazoprevir Compared to SofosbuvirContaining Regimen and Results from Studies in DifficulttoTreat Populations Merck...
View ArticleStatin use differs among Hispanic adults at risk for heart disease
In the United States adults of different HispanicLatino backgrounds at high risk for heart disease varied significantly in their use of widelyprescribed cholesterollowering medications known as statins...
View ArticleNot Taking Preventive Meds Linked to Fatal Strokes CMECE
MedPage Today Skipping antihypertensive statin or both linked to substantially higher risk
View ArticleAmarin Reaches Target Enrollment in Cardiovascular Outcomes Study of VascepaR...
BEDMINSTER NJ and DUBLIN IRELANDMarketwired March 31 2016 Amarin Corporation plc NASDAQ AMRN today announced that target patient enrollment has been reached in its REDUCEIT cardiovascular outcomes...
View ArticlePfizer Announces Positive Topline Results from Second Phase 3 LipidLowering...
SPIREAI study evaluating bococizumab administered with prefilled pen autoinjector met coprimary endpoints Pfizer Inc. announced that the Phase 3 SPIREAI AutoInjector trial of the investigational...
View ArticleApr 1 Cardiology News
Dr John Mandrola reviews new ways to think about statin benefits breast artery calcification FDA drug surveillance NOACs before AF ablation wearable cardiac defibrillators and ACC2016 in this week's...
View ArticlePfizer's PCSK9 mAb meets in Phase III
Pfizer Inc. NYSEPFE said its subcutaneous PCSK9 mAb bococizumab PF4950615 met the coprimary endpoints in the Phase III SPIREAI trial in patients with hyperlipidemia or mixed dyslipidemia receiving a
View ArticleACC HOPE Results Boost Statin Prevention Role
MedPage Today Mortality and nonfatal events reduced
View ArticleStatin blood pressure drug slash health risk in those with hypertension
April 2 Reuters Patients with high blood pressure and moderate risk of heart disease slashed their longterm risk of heart attack and stroke 40 percent by taking a blood pressure medication as well as a...
View ArticlePerioperative Statins in Cardiac Surgery and Acute Kidney Injury
Longterm statin therapy is common among patients and is particularly common among patients who undergo cardiac surgery. Among patients undergoing cardiac surgery perioperative statin therapy is...
View ArticleHighdose statin before after cardiac surgery does not reduce risk of kidney...
Among patients undergoing cardiac surgery highdose treatment with atorvastatin before and after surgery did not reduce the overall risk of acute kidney injury compared with placebo according to study...
View ArticleStatin Does Not Ward Off Acute Kidney Injury in Cardiac Surgery
Any statin use "as nephroprotective agents in patients naive to statin treatment undergoing cardiac surgery should now be abandoned" writes an observer based on the randomized trial....
View ArticleAmarin Reports Fourth Quarter and YearEnd 2015 Financial Results and Provides...
BEDMINSTER NJ and DUBLIN IRELANDMarketwired February 25 2016 Amarin Corporation plcÂNASDAQ AMRN a biopharmaceutical company focused on the commercialization and development of therapeutics to improve...
View ArticleThe Verdict on Statins and Dementia Prevention
Dr Peter Yellowlees comments on research that finally settles the question of whether statin use lowers the incidence of dementia. Medscape Psychiatry
View ArticleLipoproteina Foundation Did You Know That 63 Million Americans Have a High...
Lpa Foundation Issues Heart Month Infographic to Raise Awareness that a Simple Blood Test Could be the First Step in Preventing up to 120000 Cardiovascular Events Every Year Lipoproteina Foundation...
View Article